Allergan spin-off ASTI will begin Phase III trials of memantine in glaucoma by July.
Executive Summary
ALLERGAN SPECIALTY THERAPEUTICS MEMANTINE PHASE III TRIALS will commence in July 1998, the company stated in a recent SEC registration document. Two trials are planned; one will be in open-angle glaucoma patients receiving concomitant intraocular pressure-lowering drugs and the other will be in ocular hypertensive patients not receiving intraocular pressure- lowering drugs.